Literature DB >> 11550171

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.

C M Julian-Reynier1, L J Bouchard, D G Evans, F A Eisinger, W D Foulkes, B Kerr, I R Blancquaert, J P Moatti, H H Sobol.   

Abstract

BACKGROUND: The authors investigated the acceptability to women of the preventive strategies available for dealing with hereditary breast/ovarian carcinoma in France, the United Kingdom, and Canada, countries selected because of their cultural differences. The authors aimed to discover the existence of specific factors that may affect acceptability of these preventative measures.
METHODS: A cross-sectional, multicenter survey was conducted in Marseilles, France (n = 141), in Manchester, England (n = 130), and in Montreal, Quebec (n = 84). All of the women attending cancer genetic clinics for the first time because of a family history of breast-ovarian carcinoma completed a self-administered questionnaire before their clinic consultation.
RESULTS: Variations in responses to different preventative options presented on the questionnaire were seen within the sample of patients considered as a whole. The highest levels of acceptability were obtained for mammographic screening (87%) and chemoprevention (58%). In contrast, prophylactic oophorectomy and prophylactic mastectomy were thought to be acceptable at an early age (before 35 years), an age associated with the highest prophylactic efficacy, by only 19% and 16% of the respondents, respectively. After multivariate adjustment, the statistical data showed that the British respondents were more in favor of oophorectomy (P < 0.0001) and more in favor of chemoprevention than the French (P < 0.001) and the Canadian respondents (P < 0.001). The British (overall adjusted response [OR(adj)] = 3.9; P < 0.001) and Canadian respondents (OR(adj) = 3; P < 0.01) were more in favor of prophylactic mastectomy than the French. The cumulated acceptability of mammography before the age of 40 years was found to be greater in the French (OR(adj) = 2.8; P < 0.01) and Canadian (OR(adj) = 3.1; P < 0.05) samples than in the British sample.
CONCLUSION: These results demonstrated the existence of international variations in the acceptability of the preventive strategies available for women at risk for hereditary breast/ovarian carcinoma. Therefore, these results suggested that when establishing medical recommendations or planning public health interventions, physicians must integrate the population's perception of advantages and drawbacks with the patient's individual decision making. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11550171     DOI: 10.1002/1097-0142(20010815)92:4<959::aid-cncr1406>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

Review 1.  Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Authors:  Mary E Ropka; Jess Keim; John T Philbrick
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing.

Authors:  Vardit Kram; Tamar Peretz; Michal Sagi
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

Review 3.  Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer.

Authors:  J R J De Leeuw; M J van Vliet; M G E M Ausems
Journal:  Fam Cancer       Date:  2008-03-14       Impact factor: 2.375

4.  Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Authors:  Mary S Beattie; Beth Crawford; Feng Lin; Eric Vittinghoff; John Ziegler
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

Review 5.  Breast cancer in young women.

Authors:  Steven A Narod
Journal:  Nat Rev Clin Oncol       Date:  2012-06-26       Impact factor: 66.675

6.  Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.

Authors:  Kristi D Graves; Beth N Peshkin; Chanita H Halbert; Tiffani A DeMarco; Claudine Isaacs; Marc D Schwartz
Journal:  Breast Cancer Res Treat       Date:  2006-10-26       Impact factor: 4.872

7.  Choice of management of southern Chinese BRCA mutation carriers.

Authors:  Ava Kwong; Connie H N Wong; Catherine Shea; Dacita T K Suen; Catherine L Y Choi
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

8.  Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.

Authors:  J O Culver; C D Brinkerhoff; J Clague; K Yang; K E Singh; S R Sand; J N Weitzel
Journal:  Clin Genet       Date:  2013-02-20       Impact factor: 4.438

9.  Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Janan Karatas; Judy Wilson; Louise Heiniger; Brandi Baylock; Margaret Charles; Sue-Anne McLachlan; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

10.  Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.

Authors:  Lee Galmor; Rinat Bernstein-Molho; Miri Sklair-Levy; Dana Madoursky-Feldman; Dov Zippel; Yael Laitman; Eitan Friedman
Journal:  Breast Cancer Res Treat       Date:  2020-09-30       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.